Chemours (CC)
NYSE: CC
· Real-Time Price · USD
14.34
-0.69 (-4.59%)
At close: Aug 20, 2025, 3:59 PM
14.51
1.22%
After-hours: Aug 20, 2025, 07:43 PM EDT
Chemours Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.88B | 5.8B | 5.78B | 5.75B | 5.74B | 5.84B | 6.03B | 6B | 6.29B | 6.57B | 6.79B | 7.03B | 6.93B | 6.67B | 6.35B | 6.11B | 5.66B | 5.1B |
Cost of Revenue | 4.8B | 4.7B | 4.63B | 4.63B | 4.62B | 4.62B | 4.72B | 4.74B | 4.88B | 5.07B | 5.18B | 5.22B | 5.13B | 5.1B | 4.96B | 4.81B | 4.53B | 4.03B |
Gross Profit | 1.07B | 1.1B | 1.15B | 1.12B | 1.12B | 1.22B | 1.3B | 1.26B | 1.41B | 1.5B | 1.62B | 1.81B | 1.8B | 1.57B | 1.38B | 1.3B | 1.13B | 1.07B |
Operating Income | 91M | 420M | 458M | 375M | 341M | -198M | -83M | -62M | 182M | 779M | 878M | 1.21B | 1.15B | 1.01B | 815M | 580M | 429M | 438M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -204M | 139M | 128M | 38M | 91M | -424M | -318M | -306M | -30M | 634M | 741M | 1.11B | 1.04B | 857M | 678M | 399M | 228M | 204M |
Net Income | -420M | 31M | 87M | 69M | 116M | -330M | -237M | -308M | -88M | 489M | 578M | 908M | 882M | 747M | 609M | 395M | 257M | 215M |
Selling & General & Admin | 864M | 566M | 585M | 639M | 669M | 1.31B | 1.29B | 1.24B | 1.22B | 693M | 710M | 694M | 678M | 596M | 594M | 615M | 603M | 541M |
Research & Development | 110M | 108M | 109M | 109M | 108M | 110M | 108M | 112M | 116M | 113M | 117M | 116M | 111M | 113M | 107M | 104M | 99M | 92M |
Other Expenses | 11M | 11M | 4M | 1M | 1M | -1M | -1M | -2M | -2M | n/a | n/a | 133M | 133M | 149M | 149M | 34M | 34M | 18M |
Operating Expenses | 985M | 685M | 701M | 752M | 781M | 1.42B | 1.4B | 1.35B | 1.33B | 805M | 827M | 805M | 784M | 710M | 701M | 722M | 705M | 631M |
Interest Expense | 268M | 268M | 265M | 261M | 247M | 229M | 208M | 185M | 171M | 163M | 162M | 165M | 169M | 176M | 184M | 191M | 199M | 205M |
Selling & Marketing Expenses | 2M | 2M | n/a | -2M | -2M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.79B | 5.38B | 5.33B | 5.38B | 5.4B | 6.04B | 6.12B | 6.1B | 6.21B | 5.87B | 6B | 6.03B | 5.92B | 5.81B | 5.67B | 5.53B | 5.24B | 4.67B |
Income Tax Expense | 137M | 30M | 41M | -31M | -25M | -94M | -81M | 2M | 58M | 145M | 163M | 204M | 162M | 110M | 69M | 4M | -29M | -11M |
Shares Outstanding (Basic) | 150.24M | 149.92M | 149.83M | 149.7M | 149.41M | 149.04M | 148.59M | 148.62M | 149.1M | 149M | 150.05M | 155.38M | 156.22M | 159.9M | 165.11M | 165.11M | 166.17M | 165.65M |
Shares Outstanding (Diluted) | 150.24M | 150.41M | 149.83M | 149.7M | 150.12M | 150.05M | 148.59M | 150.19M | 149.1M | 151.18M | 150.05M | 157.85M | 159.67M | 163.58M | 168.95M | 168.95M | 170.16M | 169.05M |
EPS (Basic) | -2.8 | 0.21 | 0.59 | 0.47 | 0.78 | -2.21 | -1.59 | -2.07 | -0.66 | 3.15 | 3.64 | 5.70 | 5.46 | 4.57 | 3.69 | 2.40 | 1.56 | 1.31 |
EPS (Diluted) | -2.8 | 0.21 | 0.58 | 0.46 | 0.77 | -2.22 | -1.6 | -2.08 | -0.69 | 3.09 | 3.56 | 5.59 | 5.34 | 4.47 | 3.61 | 2.35 | 1.54 | 1.30 |
EBITDA | 237M | 640M | 672M | 571M | 598M | 75M | 199M | 192M | 451M | 1.03B | 1.12B | 1.36B | 1.31B | 1.21B | 1.03B | 930M | 779M | 758M |
EBIT | -15M | 308M | 372M | 275M | 304M | -209M | -124M | -131M | 141M | 746M | 852M | 1.09B | 1.02B | 896M | 710M | 609M | 455M | 434M |
Depreciation & Amortization | 335M | 318M | 301M | 297M | 295M | 299M | 307M | 307M | 303M | 297M | 292M | 293M | 300M | 308M | 317M | 322M | 323M | 324M |